Virtual Medicinal Product (VMP) - Buprenorphine 2.9mg / Naloxone 710microgram sublingual tablets sugar free

Name Details

Name Start Date End Date
Name Current Name Buprenorphine 2.9mg / Naloxone 710microgram sublingual tablets sugar free Start Date 01-04-2022 End Date
Abbreviated Name Abbreviated Name Buprenorphine 2.9mg / Naloxone 710microgram SL tab SF Start Date 01-04-2022

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
Schedule 3 (CD No Register)
Route
Sublingual
Form
Sublingual tablet
Ontology Form/Route
tabletsublingual.oromucosal
Free From
Sugar-free
Name Basis
Other

Codes

ATC Code
N07BC51
BNF Codes
  • BNF code 04100300
SNOMED Codes
Code Start Date End Date
40608511000001107 01-04-2022

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Buprenorphine hydrochloride Based on Base Substance Buprenorphine 2.9 mg
Naloxone hydrochloride dihydrate Based on Base Substance Naloxone 710 microgram

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet 3877 Part VIIIA Category C